By Lucy Craymer WELLINGTON--Rio Tinto PLC (RIO) has declined the New Zealand government's help in negotiations over an energy supply contract...
0511 GMT [Dow Jones] The NZX-50 adds 0.7% to 30 points to 4244.21 as investors digest corporate results. Contact Energy (CEN.NZ) rises 3.4% to...
2058 GMT [Dow Jones] The NZX-50 is likely to be relatively flat in the absence of cues from offshore markets, says Hamilton Hindin Greene broker...
NEW YORK, Sept. 7 /PRNewswire/ -- Pershing Square Capital Management, L.P. announced today that it is sending the following letter to Ceridian...
Standard & Poor's Announces Semi-Annual Reconstitution of Standard & Poor's/Barra Growth and Value Indices NEW YORK, Dec. 10 /PRNewswire/...
RNS Number:6678U CeNeS Pharmaceuticals PLC 27 January 2004 CENES PHARMACEUTICALS PLC ("the Company") HOLDING IN COMPANY The Company...
RNS Number:6672U CeNeS Pharmaceuticals PLC 27 January 2004 CENES PHARMACEUTICALS PLC ("the Company") HOLDING IN COMPANY The Company...
RNS Number:4651U CeNeS Pharmaceuticals PLC 21 January 2004 CENES PHARMACEUTICALS PLC ("the Company") HOLDING IN COMPANY The Company was...
RNS Number:4413U CeNeS Pharmaceuticals PLC 20 January 2004 CeNeS Pharmaceuticals plc Additional Listing Application has been made for...
RNS Number:3209U CeNeS Pharmaceuticals PLC 16 January 2004 CENES PHARMACEUTICALS PLC ("CeNeS" or "the Company") Notice of Extraordinary...
RNS Number:2346U CeNeS Pharmaceuticals PLC 14 January 2004 CENES PHARMACEUTICALS PLC ("the Company") HOLDING IN COMPANY The...
The Company received notification today that a client of ISIS Asset Management plc, Active Capital Trust, following the disposal of 4,500,000...
Cambridge, UK, 12 January 2004 - CeNeS Pharmaceuticals plc (LSE: CEN) ("CeNeS" or "the Company"), is pleased to announce the appointment of Piper...
RNS Number:9745T CeNeS Pharmaceuticals PLC 08 January 2004 CeNeS announces appointment of Alan Smith as non-executive director...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.